# Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

> **NCT06805695** · — · RECRUITING · sponsor: **iECURE, Inc.** · enrollment: 13 (estimated)

## Conditions studied

- Ornithine Transcarbamylase Deficiency
- Ornithine Transcarbamylase Deficiency Disease
- Urea Cycle Disorders, Inborn

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06805695
- **Lead sponsor:** iECURE, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-23
- **Primary completion:** 2041-07
- **Final completion:** 2041-07
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805695, "Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06805695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*